Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension
<strong>Background:</strong> Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high mortality. <strong>Methods:</strong> We conducted a comprehensive study of plasma metabolites using ultraperformance liquid chromatography mass spectrometry to identify p...
Asıl Yazarlar: | Rhodes, CJ, Ghataorhe, P, Wharton, J, Rue-Albrecht, KC, Hadinnapola, C, Watson, G, Bleda, M, Haimel, M, Coghlan, G, Corris, PA, Howard, LS, Kiely, DG, Peacock, AJ, Pepke-Zaba, J, Toshner, MR, Wort, SJ, Gibbs, JSR, Lawrie, A, Gräf, S, Morrell, NW, Wilkins, MR |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
American Heart Association
2016
|
Benzer Materyaller
-
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension
Yazar:: Anna Ulrich, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01) -
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?
Yazar:: Andrew J. Peacock, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01) -
Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art
Yazar:: J. Pepke-Zaba
Baskı/Yayın Bilgisi: (2010-03-01) -
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Yazar:: Sokratis Kariotis, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01) -
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Yazar:: Sokratis Kariotis, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)